Global tissue diagnostic market is expected to reach USD 6.4 billion by 2022. Tissue diagnostic,
due to its ability to detect cancer at an early stage, is expected to witness significant growth over
the forecast period. Increasing incidences of breast cancer, rising geriatric population base and
the growing demand for personalized medicines are high impact rendering drivers of the tissue
diagnostics market.
Furthermore, improving healthcare infrastructure, increasing demand for safe and cost effective
treatment and rising focus of major market players on emerging economies such as India and
China are likely to propel market growth.
Browse Full Report With TOC @
http://www.radiantinsights.com/research/tissue-diagnostic-market-analysis-by-product-instruments-accessories-by-technology-ihc-special-staining-in-situ-hybridization-digital-pathology-amp-workflow-by-application-breast-cancer-prostate-cancer-lymphoma-cancer-gastric-cancer-non-small-cell-lung-cancer-by-end-use-hospitals-cro-research-laboratories-and-segment-forecasts-to-2022
Technological advancement occurring in the field of tissue diagnostics is expected to lead towards
the availability of better option for healthcare professionals and the patients. Tissue diagnostic
procedures encompass a broad array of technologies designed to revolutionize the cancer
diagnosis process and provide apt molecular information.
Tissue diagnostic detects the presence of malignant cells by performing microscopic study of the
involved tissue. This investigation is considered to be vital for any type of cancer in order to
decide the most effective treatment line.
Further key findings from the study suggest:
Immunohistochemistry (IHC) is identified as the most lucrative sub segment of the tissue
diagnostic market majorly owing to increasing incidences of cancer diagnostic
The tissue based breast cancer diagnostic segment accounted for the largest market share in
2014. Rising alcohol consumption, lifestyle associated changes and growing geriatric population
are some factors expected to drive segment growth over the forecast period.
North America accounted for over 40.0% of the tissue diagnostic market in 2014 on account of
high usage rates of technologically advanced products. Rising patient awareness level and the
presence of accessible healthcare infrastructure is also expected to contribute towards healthy
regional market growth.
Asia Pacific is expected to witness the fastest growth over the forecast period. Rapid economic
development and the consequent improvement of the healthcare infrastructure is expected to
help manufacturers capitalize on the available opportunities in the form of unmet medical needs.
Presence of sophisticated healthcare facilities in the developed markets of Japan and Australia is
also expected to boost usage rates over the forecast period.
Key players of the tissue diagnostic market include Roche Diagnostics, Cell Signaling Technologies,
Becton Dickinson & Company, Agilent Technologies, Abbott Laboratories, GE Healthcare, Thermo
Fisher Scientific, Johnson & Johnson and Danaher Corporation.
About Us
Radiant Insights is a platform for companies looking to meet their
market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For more information visit: Radiant
Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Blog URL: http://sagarkadam.kinja.com/
No comments:
Post a Comment